Seth Klarman · Q3 2016
Baupost Group
Portfolio at the end of Q3 2016, from the 13F filed November 14, 2016. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Cheniere Energy LNG · history | 17.3% | Q1 2014 | Reduce 7% |
| Viasat VSAT · history | 12.2% | Q2 2013 or earlier | No change |
| Synchrony SYF · history | 7.0% | Q3 2016 | Buy |
| Allergan AGN · history | 6.6% | Q1 2016 | No change |
| Antero Resources AR · history | 5.6% | Q3 2014 | No change |
| PBF Energy PBF · history | 5.1% | Q3 2013 | Add 48% |
| Dell Technologies DELL · history | 4.5% | Q3 2016 | Buy |
| Twenty-First Century Fox FOXA · history | 4.4% | Q3 2015 | Add 66% |
| Theravance Biopharma TBPH · history | 3.8% | Q2 2014 | No change |
| PayPal PYPL · history | 2.9% | Q3 2015 | Reduce 12% |
| Twenty-First Century Fox FOX · history | 2.6% | Q3 2015 | No change |
| Innoviva INVA · history | 2.3% | Q2 2013 or earlier | Reduce 15% |
| Veritiv VRTV · history | 2.2% | Q3 2014 | No change |
| Keryx Biopharmaceuticals KERX · history | 1.9% | Q1 2014 | No change |
| NorthStar Asset Management NSAM · history | 1.8% | Q3 2016 | Buy |
| Olin OLN · history | 1.8% | Q3 2015 | Reduce 42% |
| VMware VMW · history | 1.7% | Q1 2016 | Reduce 29% |
| Atara Biotherapeutics ATRA · history | 1.6% | Q4 2014 | No change |
| Forward Pharma FWP · history | 1.6% | Q4 2014 | No change |
| Qurate Retail QVCA · history | 1.4% | Q2 2016 | No change |
| Colony Financial CLNY · history | 1.2% | Q3 2016 | Buy |
| ChipMOS IMOS · history | 1.1% | Q2 2013 or earlier | No change |
| NorthStar Realty Finance NRF · history | 1.0% | Q3 2016 | Buy |
| KLX KLXI · history | 1.0% | Q1 2015 | No change |
| Silver Run Acquisition SRAQ · history | 0.8% | Q2 2016 | No change |
| American International Group AIG.WS · warrants · history | 0.8% | Q2 2013 or earlier | Add 2% |
| Novagold Resources NG · history | 0.8% | Q2 2013 or earlier | No change |
| Atlanta Braves Holdings BATRK · history | 0.7% | Q2 2016 | No change |
| The ODP Corporation ODP · history | 0.7% | Q3 2016 | Buy |
| Cascadian Therapeutics CASC · history | 0.6% | Q2 2016 | No change |
| Innoviva INVA.CV · convertible notes · history | 0.6% | Q3 2014 | No change |
| Conyers Park Acquisition CPAA · history | 0.5% | Q3 2016 | Buy |
| Paratek Pharmaceuticals PRTK · history | 0.4% | Q4 2014 | No change |
| Saban Capital Acquisition SCAC.U · units · history | 0.3% | Q3 2016 | Buy |
| Credit Acceptance CACC · history | 0.3% | Q2 2016 | No change |
| Sunrun RUN · history | 0.3% | Q3 2015 | No change |
| Kindred Biosciences KIN · history | 0.2% | Q4 2013 | No change |
| Atlanta Braves Holdings BATRA · history | 0.2% | Q2 2016 | No change |
| Orexigen Therapeutics OREX · history | 0.1% | Q3 2015 | Reduce 90% |
| Tobira Therapeutics TBRA · history | 0.1% | Q3 2016 | Buy |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | No change |
| Citigroup C.WS · warrants · history | 0.1% | Q2 2013 or earlier | No change |
| Silver Run Acquisition SRAQ.WS · warrants · history | 0.1% | Q2 2016 | Reduce 24% |
| Conyers Park Acquisition CPAA.WS · warrants · history | 0.0% | Q3 2016 | Buy |
| 44 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2016, adjusted for stock splits.
Sector weighting
| Energy | 27.9% | |
|---|---|---|
| Media & telecom | 20.1% | |
| Health care | 19.8% | |
| Financials & real estate | 16.8% | |
| Technology | 7.2% | |
| Industrials | 3.4% | |
| Materials | 2.6% | |
| Consumer discretionary | 2.1% |
What changed from Q2 2016
- Buy Synchrony SYF 7.0% of the 13F
- Buy Dell Technologies DELL 4.5% of the 13F
- Buy NorthStar Asset Management NSAM 1.8% of the 13F
- Buy Colony Financial CLNY 1.2% of the 13F
- Buy NorthStar Realty Finance NRF 1.0% of the 13F
- Buy The ODP Corporation ODP 0.7% of the 13F
- Buy Conyers Park Acquisition CPAA 0.5% of the 13F
- Buy Saban Capital Acquisition SCAC.U 0.3% of the 13F
- Buy Tobira Therapeutics TBRA 0.1% of the 13F
- Buy Conyers Park Acquisition CPAA.WS 0.0% of the 13F
- Add 48% PBF Energy PBF 3.4% → 5.1%
- Add 66% Twenty-First Century Fox FOXA 2.8% → 4.4%
- Add 2% American International Group AIG.WS 0.6% → 0.8%
- Reduce 7% Cheniere Energy LNG 15.2% → 17.3%
- Reduce 12% PayPal PYPL 2.8% → 2.9%
- Reduce 15% Innoviva INVA 2.5% → 2.3%
- Reduce 42% Olin OLN 3.6% → 1.8%
- Reduce 29% VMware VMW 1.7% → 1.7%
- Reduce 90% Orexigen Therapeutics OREX 0.1% → 0.1%
- Reduce 24% Silver Run Acquisition SRAQ.WS 0.0% → 0.1%
- Sell EMC EMC was 21.0%
- Sell Citigroup C was 3.0%
- Sell Avis Budget Group CAR was 0.8%
- Sell SunEdison Semiconductor SEMI was 0.7%
- Sell Sculptor Capital OZM was 0.2%